| For: | Giri S, Mukhuty A, Mondal SA, Sahoo J, Roy A, Kamalanathan S, Naik D. Link between type 2 diabetes mellitus and hepatocellular carcinoma. World J Hepatol 2025; 17(7): 107675 [PMID: 40747219 DOI: 10.4254/wjh.v17.i7.107675] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i7/107675.htm |
| Number | Citing Articles |
| 1 |
Qin Lou, Jiarong Cai, Jianhua Yin. Mechanisms and Management Strategies of Hepatocarcinogenesis Driven by Chronic Hepatitis B Comorbid with Type 2 Diabetes. Microorganisms 2026; 14(4) doi: 10.3390/microorganisms14040853
|
| 2 |
Agnieszka Genowska, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, Katarzyna Lewtak, Krystyna Dobrowolska, Krzysztof Kanecki, Anna Parfieniuk-Kowerda, Aneta Nitsch-Osuch, Piotr Rzymski, Robert Flisiak. Nationwide Characteristics of Patients Admitted to Hospital for the First Time Due to Primary Liver Cancer and Intrahepatic Bile Duct Cancer in Poland in 2012–2023. Cancers 2026; 18(16) doi: 10.3390/cancers18162579
|
| 3 |
Mario Romeo, Fiammetta Di Nardo, Claudio Basile, Carmine Napolitano, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessia De Gregorio, Marcello Dallio, Alessandro Federico. From FIB-4 to the Artificial Intelligence Era: The Evolution of Non-Invasive Tools (NITs) for Tailored Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Livers 2026; 6(4) doi: 10.3390/livers6040071
|
| 4 |
Amedeo Lonardo, Ralf Weiskirchen. The Liver Left Behind: GLP-1 Receptor Agonists and the Prospect of Metabolic Adjuvant Therapy After HCC Resection. Metabolites 2026; 16(7) doi: 10.3390/metabo16070499
|
| 5 |
Mirjana Grocic, Madison Nguyen, Arun J. Sanyal. Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH). Diabetes, Obesity and Metabolism 2026; 28(S2) doi: 10.1111/dom.70662
|
| 6 |
Seoung Hoon Kim. New-onset diabetes and pancreatic cancer: Current evidence on absolute risk and screening feasibility. World Journal of Gastrointestinal Oncology 2026; 18(7): 121817 doi: 10.4251/wjgo.v18.i7.121817
|
| 7 |
Xiaoli Yang, Peng Fu, Hui Liu. Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1865521
|